clofibrate has been researched along with Adverse Drug Event in 13 studies
angiokapsul: contains clofibrate & insoitolnicotinate
| Excerpt | Relevance | Reference |
|---|---|---|
| " A proof of concept extension of the MOA framework is proposed for scoring confidence in the supporting data to improve scientific justification for MOA use in characterizing hazards and selecting dose-response extrapolation methods for specific chemicals." | 1.46 | Quantitative weight of evidence to assess confidence in potential modes of action. ( Becker, RA; Dellarco, V; Dourson, M; Foreman, J; Kirman, C; Kronenberg, JM; Linkov, I; Manibusan, MK; Meek, B; Palermo, C; Pottenger, LH; Schoeny, R; Seed, J, 2017) |
| " We proposed a systematic classification scheme using FDA-approved drug labeling to assess the DILI potential of drugs, which yielded a benchmark dataset with 287 drugs representing a wide range of therapeutic categories and daily dosage amounts." | 1.37 | FDA-approved drug labeling for the study of drug-induced liver injury. ( Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M | 1 |
| Vijay, V | 1 |
| Shi, Q | 2 |
| Liu, Z | 2 |
| Fang, H | 2 |
| Tong, W | 2 |
| Ding, D | 1 |
| Kelly, R | 1 |
| Sakatis, MZ | 1 |
| Reese, MJ | 1 |
| Harrell, AW | 1 |
| Taylor, MA | 1 |
| Baines, IA | 1 |
| Chen, L | 1 |
| Bloomer, JC | 1 |
| Yang, EY | 1 |
| Ellens, HM | 1 |
| Ambroso, JL | 1 |
| Lovatt, CA | 1 |
| Ayrton, AD | 1 |
| Clarke, SE | 1 |
| Morgan, RE | 1 |
| van Staden, CJ | 1 |
| Chen, Y | 1 |
| Kalyanaraman, N | 1 |
| Kalanzi, J | 1 |
| Dunn, RT | 1 |
| Afshari, CA | 1 |
| Hamadeh, HK | 1 |
| Becker, RA | 1 |
| Dellarco, V | 1 |
| Seed, J | 1 |
| Kronenberg, JM | 1 |
| Meek, B | 1 |
| Foreman, J | 1 |
| Palermo, C | 1 |
| Kirman, C | 1 |
| Linkov, I | 1 |
| Schoeny, R | 1 |
| Dourson, M | 1 |
| Pottenger, LH | 1 |
| Manibusan, MK | 1 |
| Dokianakis, SN | 1 |
| Kornaros, ME | 1 |
| Lyberatos, G | 1 |
| Begemann, H | 1 |
| Cunningham, MJ | 1 |
| Liang, S | 1 |
| Fuhrman, S | 1 |
| Seilhamer, JJ | 1 |
| Somogyi, R | 1 |
| Dry, J | 1 |
| Pradalier, A | 1 |
| Saheta, NP | 1 |
| Eipe, J | 1 |
| Moses, AM | 1 |
| Miller, M | 1 |
4 reviews available for clofibrate and Adverse Drug Event
| Article | Year |
|---|---|
[Therapeutics in 1978].
Topics: Amenorrhea; Anticholesteremic Agents; Artificial Organs; Biliary Tract Diseases; Bromocriptine; Chol | 1978 |
Iatrogenic cardiovascular disease (an aspect of preventive cardiology).
Topics: Abnormalities, Drug-Induced; Analgesics; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antidepressi | 1968 |
Drugs affecting therapy with anticoagulants.
Topics: Anticoagulants; Chloramphenicol; Clofibrate; Contraceptives, Oral; Coumarins; Diuretics; Drug Intera | 1972 |
Drug-induced dilutional hyponatremia.
Topics: Acetaminophen; Amitriptyline; Animals; Anura; Body Fluids; Carbamazepine; Chlorpropamide; Clofibrate | 1974 |
9 other studies available for clofibrate and Adverse Drug Event
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Des | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |
Quantitative weight of evidence to assess confidence in potential modes of action.
Topics: Carcinogens; Chemical Safety; Clofibrate; Drug-Related Side Effects and Adverse Reactions; Humans; M | 2017 |
On the effect of pharmaceuticals on bacterial nitrite oxidation.
Topics: Bacteria, Anaerobic; Biodegradation, Environmental; Bioreactors; Carbamazepine; Cities; Clofibrate; | 2004 |
[Hazardous ventures with medications].
Topics: Chloramphenicol; Clofibrate; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical | 1981 |
Gene expression microarray data analysis for toxicology profiling.
Topics: Acetaminophen; Animals; Benzo(a)pyrene; Clofibrate; Drug-Related Side Effects and Adverse Reactions; | 2000 |
When a drug is the culprit.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Clofibrate; Depression; Drug-Related Side Effect | 1973 |